We are looking for founders who want to build the most disruptive companies at the edge of Synthetic Biology and A.I. or Quantum Computing. While we are still building our accelerator at the moment, we want to build openly and are happy to share our journey here via press releases:
Media enquiries:
Šárka Sirůčková, Venture Associate
sarka.siruckova@thenextsequence.vc
Next Sequence, an investment fund incorporated in the US, in June 2022, is teasing at the 2023 CogX Festival,the launch of its first-of-its-kind accelerator programs dedicated to pre-seed and seed stage TechBio startups in Europe and the US.
